Article
23 Mar 2015
FDA Issues Revised Draft Guidance On Disclosures Of Risk Information In Consumer-Friendly Print Advertisements And Promotional Labeling
AUTHORS CONTENT
Article
13 Nov 2014
CMS Finalizes Proposal To Remove Continuing Medical Education Exclusion From Sunshine Act Regulations
Article
08 Aug 2014
CMS Proposes Removing CME Exclusion From Sunshine Act Regulations, Citing Redundancy With Indirect Payment Exclusion
Article
03 Jun 2014
Identifying And Mitigating Liabilities In Medical Device M&A
Article
10 Mar 2014
FDA Updates Guidance Addressing Distribution Of Scientific And Medical Publications On Unapproved New Uses
Article
15 Feb 2014
China Compliance Update: Commercial Bribery Risks Remain Very Real In China
Article
29 Jan 2014
FDA Issues Draft Guidance Addressing Postmarket Submission Requirements For Internet-based Promotional Materials
Article
25 Jan 2014
New Law Extends Federal Oversight Of Compounding Pharmacies, Establishes National Drug Track-and-Trace Requirements
Article
24 Sep 2013
Whistleblowing In China And The United States
Article
09 May 2013
Draft Guidance Outlines Recommendations For Formal Meetings Between FDA And Biosimilar Sponsors And Applicants
Article
08 Apr 2013
Supreme Court Hears Oral Argument In "Pay-For-Delay" Patent Settlement Antitrust Case
Article
18 Dec 2012
Federal Court Vacates Conviction For Truthful Off-Label Promotion Of FDA-Approved Drug
Article
09 Aug 2012
New Flexibility For Pharmaceutical And Medical Device Companies In Massachusetts, But At A Price
Article
14 May 2012
CMS To Extend Timetable For Implementation Of The Physician Payments Sunshine Act
Article
19 Apr 2012
FDA Finalizes Benefit-Risk Determination Methodology For Certain Medical Devices
Article
16 Apr 2012
FDA Schedules Public Hearing To Evaluate Potential New Drug Approval Paradigm
Article
13 Apr 2012
FDA Issues Draft Guidance Implementing Direct-To-Consumer Television Ad Pre-Dissemination Review Program
Article
22 Feb 2012
FDA Publishes Draft Biosimilars Guidance
Article
07 Feb 2012
FDA Clarifies Use Of Product Names In Advertising And Promotional Labeling
Article
10 Jan 2012
FDA Issues Draft Guidance, Requests Public Comments On Communication Of Off-Label Information